I think emotions should be kept aside when investing( easier said then done). If there was an approval everyone would be singing praises of mesoblast and management. The management took a chance by resubmitting BLA and received a CRL. Clearly they know more then us shareholders. I think this was an overreaction on the stock price and many dont want to wait anymore given 2 failures in succession. I dont think the company is going anywhere and neither is the science. Some clarity will come on the way forward after the next meeting with FDA. If its another trial so be it but I hope there is a middle way. Lets hope for the best .
Ann: Update on BLA for Graft Versus Host Disease, page-1015
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |